Education
About Us
Working with TipRanks
Follow Us
CSTK - ETF AI Analysis
Top Page
Invesco Comstock Contrarian Equity ETF (CSTK)
Rating:70Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Mix of Defensive and Growth Companies
Top holdings include well-known health care, technology, and communication services companies that can provide a balance of stability and growth potential.
Moderate Expense Ratio
The fund’s fee level is reasonable for an actively managed equity ETF, allowing investors to keep more of their returns compared with higher-cost options.
Negative Factors
Heavy U.S. Market Focus
With almost all assets in U.S. stocks, the fund offers little geographic diversification and is highly tied to the U.S. market’s ups and downs.
Financial Sector Concentration
A large allocation to financial stocks, including several top holdings, means the fund could be hit hard if the financial sector weakens.
Several Lagging Top Holdings
Some of the largest positions, particularly in financials and technology, have shown weak recent performance, which can drag on overall returns.
CSTK vs. SPDR S&P 500 ETF (SPY)
AUM118.30M
RegionGlobal
Expense Ratio0.35%
Beta0.83
IssuerInvesco
Inception DateMay 07, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,541
30 Day Avg. Volume5,932
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
34.67Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering55
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CSTK Summary
The Invesco Comstock Contrarian Equity ETF (CSTK) is an actively managed fund that looks for undervalued stocks across the total U.S. market, with a value-focused, contrarian approach. It doesn’t track a set index, but instead picks companies the managers believe are priced below their true worth. The fund holds well-known names like Alphabet (Google) and Bank of America, and spreads investments across many sectors, which can help with diversification and potential long-term growth. A key risk is that these “out of favor” value stocks can stay unpopular for long periods, so the share price can go up and down more than you expect.
How much will it cost me?The Invesco Comstock Contrarian Equity ETF (CSTK) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it’s actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The CSTK ETF could benefit from a global economic recovery, which may boost undervalued companies across sectors like financials, healthcare, and technology, where it has significant exposure. However, rising interest rates or regulatory changes in key sectors like financials and healthcare could negatively impact its holdings, while global economic uncertainty might weigh on its contrarian investment strategy. Its focus on undervalued companies provides potential for growth but also carries risks if market conditions remain unfavorable.
CSTK Top 10 Holdings
CSTK leans heavily into financials, with Bank of America, Wells Fargo, State Street, and Citizens Financial acting as the fund’s core engine. These banks have been mostly steady to rising in recent months, even if their year-to-date paths have been a bit bumpy. Chevron and FedEx are the real bright spots, with both stocks climbing and giving the ETF a lift, while CVS Health has been more of a drag as it struggles to gain traction. Alphabet and Cisco add a tech twist, but overall this is a globally oriented, value-tilted portfolio with a clear tilt toward U.S. financials and industrial-style workhorses.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Chevron | 4.00% | $4.62M | $393.03B | 28.23% | 71 Outperform | |
| Alphabet Class A | 3.80% | $4.39M | $3.67T | 86.50% | 85 Outperform | |
| Bank of America | 3.55% | $4.10M | $338.24B | 18.80% | 72 Outperform | |
| ― | 3.35% | $3.87M | ― | ― | ― | |
| Cisco Systems | 3.01% | $3.48M | $307.06B | 30.28% | 77 Outperform | |
| CVS Health | 2.93% | $3.39M | $96.78B | 15.70% | 64 Neutral | |
| Wells Fargo | 2.92% | $3.37M | $232.19B | 9.92% | 80 Outperform | |
| FedEx | 2.90% | $3.36M | $83.03B | 46.54% | 79 Outperform | |
| State Street | 2.77% | $3.20M | $34.34B | 45.86% | 75 Outperform | |
| Microsoft | 2.45% | $2.83M | $2.98T | 6.10% | 79 Outperform |
CSTK Technical Analysis
Negative
―
Price Trends
30.21
Negative
29.27
Negative
28.15
Positive
Market Momentum
-0.29
Positive
28.11
Positive
4.05
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CSTK, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 30.37, equal to the 50-day MA of 30.21, and equal to the 200-day MA of 28.15, indicating a neutral trend. The MACD of -0.29 indicates Positive momentum. The RSI at 28.11 is Positive, neither overbought nor oversold. The STOCH value of 4.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CSTK.
CSTK Peer Comparison
Comparison Results
Performance Comparison
CSTK
Invesco Comstock Contrarian Equity ETF
29.11
4.35
17.57%
RGEF
Rockefeller Global Equity ETF
―
―
―
GMOI
GMO International Value ETF
―
―
―
FPAG
FPA Global Equity ETF
―
―
―
MFSV
MFS Active Value ETF
―
―
―
COPY
Tweedy Browne Insider + Value ETF Trust Units
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents